Patents by Inventor Laura DAVID

Laura DAVID has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11786615
    Abstract: The invention provides a unit operation formed by a device and its use for continuous virus inactivation of a continuous flow of a process fluid. The unit operation formed by a device comprises a single inlet at one end and an outlet at the opposite end and at least one HFI, characterized in that the HFI further comprises at least one installation.
    Type: Grant
    Filed: September 18, 2018
    Date of Patent: October 17, 2023
    Assignee: Bayer Aktiengesellschaft
    Inventors: Martin Lobedann, Laura David, Sven-Oliver Borchert, Lisa Marie Waldschmidt
  • Publication number: 20220073560
    Abstract: Described herein is a method for transferring of batch production process for a monoclonal antibody to a continuous production process for the same monoclonal antibody.
    Type: Application
    Filed: January 8, 2020
    Publication date: March 10, 2022
    Applicant: Bayer Aktiengesellschaft
    Inventors: Bastian BUDDE, Peter SCHWAN, Sven-Oliver BORCHERT, Benjamin MAISER, Sven CLASSEN, Jürgen LENZ, Laura DAVID, Martin LOBEDANN
  • Publication number: 20210069359
    Abstract: The invention provides a unit operation formed by a device and its use for continuous virus inactivation of a continuous flow of a process fluid. The unit operation formed by a device comprises a single inlet at one end and an outlet at the opposite end and at least one HFI, characterized in that the HFI further comprises at least one installation.
    Type: Application
    Filed: September 18, 2018
    Publication date: March 11, 2021
    Inventors: Martin LOBEDANN, Laura DAVID, Sven-Oliver BORCHERT, Lisa Marie WALDSCHMIDT
  • Patent number: 10894991
    Abstract: Disclosed herein is a method for validation of continuous viral clearance comprising the steps of providing a probe to be validated, spiking the probe in a valid manner, performing viral clearance, sampling the spiked probe and analyzing the sample of the spiked probe of step d).
    Type: Grant
    Filed: October 20, 2017
    Date of Patent: January 19, 2021
    Assignee: BAYER AKTIENGESELLSCHAFT
    Inventors: Benjamin Maiser, Peter Schwan, Laura David, Martin Lobedann
  • Publication number: 20190316213
    Abstract: Disclosed herein is a method for validation of continuous viral clearance comprising the steps of providing a probe to be validated, spiking the probe in a valid manner, performing viral clearance, sampling the spiked probe and analyzing the sample of the spiked probe of step d).
    Type: Application
    Filed: October 20, 2017
    Publication date: October 17, 2019
    Inventors: Benjamin MAISER, Peter SCHWAN, Laura DAVID, Martin LOBEDANN